Physician profile
Peter J Panton
NPI 1063401784
$1,675.90
in general payments reported to CMS, 2019-2025
9 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $164 · 2021: $150 · 2022: $361 · 2023: $220 · 2024: $186 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $817.09 | 2019-2025 | Clareon, Argos |
| Allergan, INC. | $209.57 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $194.62 | 2019 | |
| Horizon Therapeutics Plc | $141.48 | 2020-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $113.21 | 2023 | Miebo |
| Carl Zeiss Meditec USA, INC. | $86.79 | 2022 | |
| Aerie Pharmaceuticals, INC. | $44.67 | 2019 | |
| Eyevance Pharmaceuticals LLC | $44.30 | 2020 | |
| New World Medical,INC. | $24.17 | 2025 | Clearpath, Kahook Dual Blade, Via360 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Panton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.